Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Malignant peripheral nerve sheath tumor of the right forearm: Case report.

International journal of surgery case reports·2025

Same author

Thoracic Endovascular Aortic Repair (TEVAR) for Grade III Traumatic Thoracic Aortic Injury.

Cureus·2025

Same author

An Unusual Paraganglioma of the Left Vagus Nerve: A Surgical Conundrum.

Cureus·2025

Same author

Two Simultaneous Primary Cancers: A Case Report.

Cureus·2025

Same author

Giant Frontoethmoidal Encephalocele in an Infant: A Case Report.

Cureus·2025

Same author

[MURCS association: case report].

Ginecologia y obstetricia de Mexico·2008

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Giant Uterine Tumor Compatible With Sarcoma.

Elias Gallardo-Navarro¹, Alfredo Saad Ganem², Adriana Margarita Acosta Blanco²

¹General Surgery, Hospital Español, Mexico City, MEX.

|April 7, 2025

Summary

Uterine sarcomas are rare mesenchymal tumors with poor prognosis, often diagnosed late. This case highlights the challenges in managing these aggressive cancers, even with extensive treatment.

Keywords:

abdominal mass abdominal radical hysterectomy metastasis sarcoma uterine tumor

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Jun 2, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Area of Science:

Gynecologic Oncology
Mesenchymal Neoplasms

Background:

Uterine sarcomas are rare, accounting for ~4% of uterine malignancies.
They originate from the uterus's connective tissue (mesenchyme) and are histologically diverse.
Early detection is challenging, with diagnosis often confirmed via pathological studies.

Observation:

A 78-year-old woman presented with abdominal pain, fatigue, and abdominal distension.
She underwent a radical hysterectomy for a large uterine sarcoma (6.115 kg).
Post-operatively, she experienced hypovolemic shock but recovered for adjuvant therapy.

Findings:

Despite surgery and adjuvant chemotherapy/radiotherapy, the patient died from disease progression within three weeks.
Uterine sarcoma exhibits varied histology and biological activity, complicating classification.
Treatment guidelines rely on retrospective data, hindering effective clinical management.

Implications:

This case underscores the aggressive nature and poor prognosis of uterine sarcomas.
The difficulty in classification and lack of robust treatment data present significant clinical challenges.
Further research into standardized diagnostic and therapeutic strategies for uterine sarcomas is crucial.